Hidden Heroes of Health Care: Supporting a Shortage of Molecular Genetic Technologists
A Molecular Genetic Technologist is a qualified technologist (by an academic or applied education) that is able to perform testing on human samples for inherited diseases, acquired diseases and infectious diseases. According to the Mayo Clinic, these technologists analyze a patient's DNA to research, diagnose and treat many different diseases and disorders, such as cancers, congenital and nervous system disorders.
Ericka Hendrix, PhD, MB(ASCP), is a Professor and Program Director of Molecular Pathology M.S. at TTUHSC. We sat down with her to talk about the shortage of Molecular Genetic Technologists and how the TTUHSC Molecular Pathology Program is bringing awareness to the profession.
Shortage in Laboratory Sciences

The reason for this shortage? Current technologists are retiring, and COVID-19 pushed up that timeline for many after an increase in testing during that time. But because this field of health care is so “hidden,” there are not enough new technologists to fill the gaps.
“As Molecular Genetic Technologists, we specifically test for things that we detect in DNA and RNA,”she says. “So, when we can detect viruses like COVID, our workload increases dramatically without any new people coming on board.”
Hendrix also explains that because of COVID, many labs bought molecular equipment to run tests to detect the virus. Now that the pandemic has subsided, a lot of those instruments aren’t being used because there is a shortage of professionals that have the skills to bring on new molecular diagnostic tests.
Increasing Awareness
TTUHSC’s Molecular Pathology Program is one of eight in the nation that graduates students who are eligible to be certified in molecular biology, and to ultimately be able to perform this high complexity molecular diagnostic testing.
TTUHSC’s one-year graduate program is the largest in the nation. To support this shortage in Molecular Genetic Technologists, Hendrix says the program has teamed up with professional organizations (i.e. Program Director Advisory Committee) to help support program directors in teaching molecular biology, to encourage including it in their courses, or to even start molecular programs.
“We use Facebook for outreach,” Hendrix explains. “And I mentor new program directors to help keep these programs open and get new programs started.”
Hendrix says the TTUHSC Molecular Pathology Program is also trying to help this shortage by submitting an NIH grant to create workshops, so that people can learn the basics about molecular diagnostic testing in two weeks.
“We're trying to raise awareness to get people interested in the field,” she says. “I think the major hurdle for our field is that people don't know about it.”
Although there is currently a shortage of Molecular Genetic Technologists, Hendrix shares that the job growth rate in the field is expected to continue growing. She estimates that globally, it is currently a 17.3 billion dollar field, but by 2029 it is projected to be a 32.7 billion dollar field.
“Our advanced techniques of being able to sequence whole genomes has really spurred the advancement of this field and the continued growth,” Hendrix says. “But we need technologists that can run and analyze that really complex data.”
Related Stories
TTUHSC Professor and Surgeon Receives National Award
The American Burn Association (ABA) recently presented the prestigious Lifetime Achievement Award to TTUHSC professor and burn surgeon John A. Griswold, M.D.
Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock
As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.
U.S. News & World Report Ranks TTUHSC Schools Among Best for 2025 Graduate School Rankings
Several graduate programs at TTUHSC have been recognized in the 2025 U.S. News & World Report Best Graduate School Rankings, reaffirming the university’s continued excellence in health sciences education and training.
Recent Stories
TTUHSC Researchers to Study Gene’s Role in Prostate Cancer Metastasis
With support from a three-year, $1.85 million grant, Srinivas Nandana, Ph.D., and co-investigator Manisha Tripathi, Ph.D., from the Department of Cell Biology and Biochemistry at the TTUHSC School of Medicine will investigate the role of TBX2.
TTUHSC Professor and Surgeon Receives National Award
The American Burn Association (ABA) recently presented the prestigious Lifetime Achievement Award to TTUHSC professor and burn surgeon John A. Griswold, M.D.
TTUHSC Researcher Receives National Award
The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.